AI×Bio's wild week: phage therapy in a human, toxin binders, 32-minute drug leads
HealthcareAIGuy · x · 2026-10-23
A roundup of a packed week in AI×bio:
- Radical Numerics' Omnii-1 designed phages delivered to a human patient
- 17 scorpion-toxin binders designed with Claude validated in the lab
- OpenAI acquired Orchestra Bio; OpenAI + PerturbAI agents found neurodegeneration leads in 32 minutes
- RFD4-Proteina open programmable protein design model, BioEmu2 biomolecular simulation, and the Chaperone agent framework all shipped
The author runs a free weekly newsletter for 60,000+ healthtech professionals, investors, and founders.
More from Venture
- Study: 88% of VC-backed founders get zero at exit — liquidation preferences explained — Zachly · 2026-10-24
- Retail trader round-trips $27.6M account down to $600K in four months — mdancho84 · 2026-10-24
- Replit acquires Chroma to build the context layer for AI agents — amasad · 2026-10-24
- $16.3B revenue, $80.7B net loss — and a $2T IPO valuation — gaganghotra_ · 2026-10-24
- a16z charts: US media consumption plateaus at ~25 hrs/week as YouTube and social eat everything else — a16z · 2026-10-24
- Indie dev ships three Windows apps built with Claude Code to Microsoft Store — raudlaur · 2026-10-24